Health Literacy and Its Importance in Workers' Compensation June 19, 2025
Event Details
Please note that you can not receive CE credits for watching past webinars.
Please note that you can not receive CE credits for watching past webinars.
Explore how rising regulatory activity, AI oversight and evolving workplace policies are reshaping workers’ comp claims management. In this Claims Journal article, Enlyte experts break down the compliance, litigation and operational risks organizations should be watching closely.
In this Enlyte Envision podcast episode, host Tom Kerr interviews experts Roland Kratzer and Alex Rose about optimizing utilization review programs for auto casualty payers.
Rising temperatures are putting new focus on heat-related workplace injuries and workers’ comp exposure. In this Business Insurance article, Michele Hibbert discusses emerging risks, evolving claims concerns and how employers and insurers are responding as heat scrutiny grows.
Aging workforce strategies for workers’ comp help employers manage claim severity, injury prevention and return-to-work planning. Learn key risks.
Overall cost and utilization by claim were down in 2025 even with 6 of the top 10 therapeutic classes experiencing rising cost per script. Migraine medications rose by nearly 10%, representing the largest script cost gains driven in part by increases in brand Average Wholesale Price (AWP) including brand AWP for migraine medications increasing 2.4%. Utilization per claim also jumped in the migraine medication class (up 9.6%), while every other class within the top 10 (besides topicals, which rose 2.5%) experienced decreased utilization.
The U.S. share of repairable collision claims involving battery electric vehicles (BEVs) held steady at 3.33% in Q1 2026, unchanged from Q4 2025. Although sales of new BEVs grew modestly quarter over quarter, they remain 28% lower year over year. Several OEMs have scaled back production following increases in import tariffs and the expiration of federal tax incentives. Despite this near-term slowdown, BEVs are projected to reach approximately 29% of new vehicle sales and just over 10% of vehicles in operation by 2035, driving a steady increase in collision exposure.